Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

780 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
Montaner J, Fernández-Cadenas I, Molina CA, Monasterio J, Arenillas JF, Ribó M, Quintana M, Chacón P, Andreu AL, Alvarez-Sabín J. Montaner J, et al. Among authors: quintana m. Stroke. 2003 Dec;34(12):2851-5. doi: 10.1161/01.STR.0000098648.54429.1C. Epub 2003 Nov 6. Stroke. 2003. PMID: 14605329 Clinical Trial.
Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.
Alvarez-Sabín J, Delgado P, Abilleira S, Molina CA, Arenillas J, Ribó M, Santamarina E, Quintana M, Monasterio J, Montaner J. Alvarez-Sabín J, et al. Among authors: quintana m. Stroke. 2004 Jun;35(6):1316-22. doi: 10.1161/01.STR.0000126827.69286.90. Epub 2004 Apr 15. Stroke. 2004. PMID: 15087562
Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.
Hernandez-Guillamon M, Garcia-Bonilla L, Solé M, Sosti V, Parés M, Campos M, Ortega-Aznar A, Domínguez C, Rubiera M, Ribó M, Quintana M, Molina CA, Alvarez-Sabín J, Rosell A, Unzeta M, Montaner J. Hernandez-Guillamon M, et al. Among authors: quintana m. Stroke. 2010 Jul;41(7):1528-35. doi: 10.1161/STROKEAHA.110.584623. Epub 2010 Jun 10. Stroke. 2010. PMID: 20538694
Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients.
Fernández-Cadenas I, Del Río-Espínola A, Carrera C, Domingues-Montanari S, Mendióroz M, Delgado P, Rosell A, Ribó M, Giralt D, Quintana M, Castellanos M, Obach V, Martínez S, Freijo MM, Jiménez-Conde J, Roquer J, Martí-Fábregas J, Molina CA, Alvarez-Sabín J, Montaner J. Fernández-Cadenas I, et al. Among authors: quintana m. Stroke. 2012 May;43(5):1398-400. doi: 10.1161/STROKEAHA.111.639823. Epub 2012 Apr 10. Stroke. 2012. PMID: 22496335
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, Quintana M, Palacios ME, Molina CA, Alvarez-Sabín J. Montaner J, et al. Among authors: quintana m. Stroke. 2008 Aug;39(8):2280-7. doi: 10.1161/STROKEAHA.107.505354. Epub 2008 Jun 5. Stroke. 2008. PMID: 18535284
780 results